March 27, 2017
Mesoblast (MESO) $40 M offering of 26.25 M shares priced at AUS2.00
March 22, 2017
Bellicum Pharmaceuticals (BLCM) proposes 5M share offering at $12.00 per share
March 21, 2017
REGENXBIO (RGNX) proposes 3.7 M share offering priced at $20.50 for proceeds of $75 M
March 17, 2017
Northwest Bio (NWBO) yet another offering, this time of $7.5 M
March 7, 2017
Fibrocell Sciences (FCSC) proposes convertible preferred 8 M unit financing for $8 M
February 10, 2017
Biostage (BSTG) offering of 20 M common and 100% warrant coverage at $0.40
February 9, 2017
BioTime (NYSEMKT: BTX) Proposes offering of 6.48 M shares at $2.70
January 26, 2017
Athersys (ATHX) prices offering at $1.01 and is DOWN -$0.48 in the pre-market
January 19, 2017
Stemline Therapeutics (STML) proposes 4.5 M share $45 M offering, priced at $10.00
January 18, 2017
Pluristem (PSTI) upsizes share offering to 12.22 M shares with 50% warrant coverage priced at $1.225
December 15, 2016
Vericel (VCEL) proposes 6.2 M share $17 M offering at $2.75
November 22, 2016
Fate Therapeutics (FATE), a $13.30 preferred combined with a $2.66 per share private placement for proceeds of $57 M
October 27, 2016
TiGenix NV (Euronext Brussels: TIG) proposes U.S. IPO
October 21, 2016
Northwest Biotherapeutics (NWBO) proposes 14 M share RDO at $0.38 to raise $5 M
October 19, 2016
Organovo Holdings (ONVO) proposes 9 M share offering at $2.75 per share to raise $25 M
October 6, 2016
AxoGen (AXGN) proposes offering of 2.33 M shares priced at $7.50
September 16, 2016
Histogenics Corporation (HSGX) proposes $30 M Private Placement
September 15, 2016
Capricor Therapeutics (CAPR) proposes public offering of 3 M shares at $3.20
September 15, 2016
Caladrius Biosciences (CLBS) $25M two tranche At-market-offering without warrants - SELL
September 7, 2016
BioLife Solutions (BLFS), cash getting tight?
August 30, 2016
OncoCyte Corporation (NYSEMKT: OCX) 3.24 M unit sale with 100% warrant coverage raises $10.5 M
August 23, 2016
Northwest Bio (NWBO) reprices warrants to raise cash
August 9, 2016
Fibrocell Science (FCSC) ditches share and warrant offering for $25 M convertible promissory notes and warrants
August 9, 2016
Immunocellular (NYSEMKT: IMUC) files 47 M shares offering at $0.16 with 32.25 M warrants to raise $7.4 M
August 8, 2016
Fibrocell Science (FCSC) files for an underwritten public offering.
5 hours 41 min ago
RegMed Investors’ (RMi) pre-open: what will be, will be
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors